Yayın:
Estimating return on investment (ROI) with increased utilization of HIV pre-exposure prophylaxis (PrEP) among key populations in France

Basit öğe sayfası
dc.contributor.authorAyer, Turgay
dc.contributor.authorGursel, Emir
dc.contributor.authorEdali, Mert
dc.contributor.authorIdelovici-Marchal, Claire
dc.contributor.authorBenabadji, Elias
dc.contributor.authorJarrett, James
dc.contributor.authorMezzio, Dylan
dc.contributor.institutionauthorEDALI, Mert
dc.date.accessioned2026-06-27T15:14:52Z
dc.date.issued2024
dc.identifier.eissn1758-2652
dc.identifier.endpage234
dc.identifier.startpage233
dc.identifier.urihttps://hdl.handle.net/20.500.14981/69448
dc.identifier.volume27
dc.identifier.wos001413575300281
dc.language.isoeng
dc.publisherJOHN WILEY & SONS LTD
dc.relation.ispartofJOURNAL OF THE INTERNATIONAL AIDS SOCIETY
dc.subjectImmunology
dc.subjectInfectious Diseases
dc.titleEstimating return on investment (ROI) with increased utilization of HIV pre-exposure prophylaxis (PrEP) among key populations in France
dc.typeMeeting Abstract
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar